Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
42.59
-1.89 (-4.25%)
Feb 21, 2025, 4:00 PM EST - Market closed
Ultragenyx Pharmaceutical Market Cap
Ultragenyx Pharmaceutical has a market cap or net worth of $3.94 billion as of February 21, 2025. Its market cap has increased by 7.19% in one year.
Market Cap
3.94B
Enterprise Value
4.10B
1-Year Change
7.19%
Ranking
Category
Stock Price
$42.59
Market Cap Chart
Since January 31, 2014, Ultragenyx Pharmaceutical's market cap has increased from $1.19B to $3.94B, an increase of 231.37%. That is a compound annual growth rate of 11.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 4.11B | 5.91% |
| Dec 31, 2024 | 3.88B | -1.06% |
| Dec 29, 2023 | 3.93B | 20.90% |
| Dec 30, 2022 | 3.25B | -43.33% |
| Dec 31, 2021 | 5.73B | -32.17% |
| Dec 31, 2020 | 8.45B | 242.48% |
| Dec 31, 2019 | 2.47B | 12.20% |
| Dec 31, 2018 | 2.20B | 11.33% |
| Dec 29, 2017 | 1.98B | -31.24% |
| Dec 30, 2016 | 2.87B | -34.05% |
| Dec 31, 2015 | 4.36B | 211.25% |
| Dec 31, 2014 | 1.40B | 17.73% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 783.24B |
| UnitedHealth Group | 463.16B |
| Johnson & Johnson | 383.82B |
| Novo Nordisk | 370.06B |
| AbbVie | 352.32B |
| Abbott Laboratories | 230.19B |
| AstraZeneca | 227.07B |
| Merck & Co. | 219.67B |